Akili Has Received A Notice Of Allowance For U.S. Patent Application 17/890,478 Titled "Cognitive Platform For Deriving Effort Metric For Optimizing Cognitive Treatment (Using Data Computed With Artificial Neural Network Or Deep Learning Techniques)"
Akili Has Received A Notice Of Allowance For U.S. Patent Application 17/890,478 Titled "Cognitive Platform For Deriving Effort Metric For Optimizing Cognitive Treatment (Using Data Computed With Artificial Neural Network Or Deep Learning Techniques)"
Akili已收到美國專利申請許可通知 17/890,478 號，標題爲 “用於推導用於優化認知治療的努力度量的認知平台（使用通過人工神經網絡或深度學習技術計算的數據）”
Akili Has Received A Notice Of Allowance For U.S. Patent Application 17/890,478 Titled "Cognitive Platform For Deriving Effort Metric For Optimizing Cognitive Treatment (Using Data Computed With Artificial Neural Network Or Deep Learning Techniques)"
Akili已收到美國專利申請許可通知 17/890,478 號，標題爲 “用於推導用於優化認知治療的努力度量的認知平台（使用通過人工神經網絡或深度學習技術計算的數據）”
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。